Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
aratinga.bio logo — aratinga.bio develops immunotherapies to treat cancer, inclu...

aratinga.bio

aratinga.bio develops immunotherapies to treat cancer, including CAR T-cell platform for hematological and solid tumors.

Founded 2017 France France 2-10 employees Biotechnology

General Information

Company Name aratinga.bio
Founded Year 2017
Location France France
Employees 2-10
Industries Biotechnology
Social

BounceWatch is an independent company data service, not affiliated with aratinga.bio. To contact aratinga.bio, visit aratinga.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does aratinga.bio compare?

A PDF of aratinga.bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting aratinga.bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About aratinga.bio

aratinga.bio is a preclinical stage biotechnology startup founded in 2017 and based in France. The company is dedicated to pioneering innovative immunotherapies for cancer treatment, particularly focusing on advancing a distinct CAR T-cell platform capable of effectively targeting both hematological and solid tumors, irrespective of prior treatments. Their slogan, "aratinga.bio develops immunotherapies to treat cancer, including CAR T-cell platform for hematological and solid tumors," encapsulates their core mission. Currently, there is no publicly disclosed information regarding their last investment or the parties involved in it. With a strong vision and a promising approach to tackling cancer, aratinga.bio demonstrates potential for disruption in the biotechnology and oncology sectors.

Business keywords: immunotherapy, cancer treatment, CAR T-cell therapy, preclinical stage, oncology, innovation, hematological cancers, solid tumors, proprietary platform, novel therapies

No funding data available for aratinga.bio yet.

aratinga.bio Alternatives & Competitors

View All Alternatives
aratinga.bio vs
Immugenia Inc.
Immugenia Inc.

Developing the next generation CAR therapy using hemopoietic stem cells to treat cancer and prevent...

Pre-Seed
3 employees
Biotechnology, Health and Wellness
aratinga.bio vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
aratinga.bio vs
Novelogics Biotechnology Inc.
Novelogics Biotechnology Inc. Canada

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “In...

Angel
1 employees
Biotechnology, Health Care
View all alternatives

FAQ About aratinga.bio

aratinga.bio develops immunotherapies to treat cancer, including CAR T-cell platform for hematological and solid tumors.
aratinga.bio was founded in 2017.
aratinga.bio is headquartered in France.
aratinga.bio operates in Biotechnology. Its work centres on immunotherapy, cancer treatment, CAR T-cell therapy and preclinical stage.
aratinga.bio has approximately 2-10 employees.
Top alternatives and competitors to aratinga.bio include Immugenia Inc., Prescient Therapeutics, Novelogics Biotechnology Inc., Cytovia Therapeutics, PACT Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
aratinga.bio and Immugenia Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for aratinga.bio, https://bouncewatch.com/company/aratingabio, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout